Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Handling of AMD Method Notebooks – V 2.0

Posted on By

Analytical Method Development: Handling of AMD Method Notebooks – V 2.0

SOP for Handling Method Development Notebooks in the AMD Department


Department Analytical Method Development
SOP No. SOP/AMD/038/2025
Supersedes SOP/AMD/038/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP describes the procedures for the issuance, utilization, review, and archival of Analytical Method Development (AMD) notebooks used to record method development trials, observations, and data. The objective is to ensure consistency, traceability, and compliance with ALCOA+ principles, GMP, and data integrity requirements.

2. Scope

This SOP is applicable to all bound notebooks used by scientists and analysts in the AMD department to record experimental data, observations, instrument settings, and method development outcomes related to APIs and formulations.

3. Responsibilities

  • Analytical Scientist: Records entries in a timely, legible, and compliant manner in the method notebook.
  • QA: Issues, reviews, and archives completed notebooks; audits for compliance with data integrity principles.
  • Department Coordinator: Maintains the issuance and return log of notebooks.
  • Head – AMD: Approves the closure of notebooks and ensures training of personnel on notebook handling practices.
See also  Analytical Method Development: Preparation of Method Development Report - V 2.0

4. Accountability

The Head of AMD is accountable for enforcing the SOP on notebook handling and ensuring no unofficial records are used for capturing method development data.

5. Procedure

5.1 Notebook Format and Structure

  1. All notebooks used must be:
    • Bound with numbered pages
    • Free from removable sheets or post-its
    • Pre-labeled with a unique Notebook ID (e.g., AMD/NB/001)
  2. Each notebook must include:
    • Index page
    • User identification page
    • Issued and returned dates

5.2 Notebook Issuance

  1. Request new notebooks by submitting Annexure-1: Notebook Requisition Form to QA.
  2. QA records issuance in Annexure-2: Notebook Issuance Log and updates master list.
  3. The scientist signs the issuance log and becomes accountable for its use.

5.3 Recording Entries

  1. All entries must be:
    • Made in black or blue permanent ink
    • Dated and signed by the analyst
    • Verified by a second person, where applicable
  2. Experimental design, rationale, trial conditions, and observations must be recorded real-time.
  3. Diagrams, chromatograms, and tables may be pasted and cross-referenced to instrument IDs.

5.4 Corrections and Blank Spaces

  1. Do not overwrite or use correction fluids.
  2. To correct an error:
    • Strike through with a single line
    • Initial, date, and provide justification
  3. Blank spaces must be ruled off with diagonal lines and annotated as “Cancelled.”
See also  Analytical Method Development: Drafting Analytical Specifications - V 2.0

5.5 Notebook Review and Closure

  1. Upon completion, the analyst submits the notebook to QA for review and closure.
  2. QA verifies:
    • Page integrity and sequence
    • Signatures, dates, and correction practices
    • Data completeness and consistency
  3. QA documents review in Annexure-3: Notebook Review Checklist.

5.6 Notebook Archival

  1. Closed notebooks are labeled “ARCHIVED” and stored in a secure, humidity-controlled area.
  2. QA updates Annexure-4: Notebook Archival Register with retrieval tracking information.
  3. Retention period shall be a minimum of 10 years unless regulatory requirements specify longer.

5.7 Loss or Damage of Notebook

  1. Report immediately to QA and Head – AMD using Annexure-5: Notebook Incident Report.
  2. Initiate deviation management procedure as per SOP/QMS/042/2025.
  3. Impact assessment to be performed on lost data and reported in closure document.

6. Abbreviations

  • AMD: Analytical Method Development
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure
  • ID: Identification

7. Documents

  1. Notebook Requisition Form – Annexure-1
  2. Notebook Issuance Log – Annexure-2
  3. Notebook Review Checklist – Annexure-3
  4. Notebook Archival Register – Annexure-4
  5. Notebook Incident Report – Annexure-5

8. References

  • WHO TRS 1019 Annex 5 – Good Data and Record Management Practices
  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 11 – Electronic Records; Electronic Signatures (where applicable)
See also  Analytical Method Development: Analytical Control Strategy Development - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Notebook Requisition Form

Date Requested By Designation Purpose Approved By
01/05/2025 Rajesh Kumar Analyst Method Trials Sunita Reddy

Annexure-2: Notebook Issuance Log

Notebook ID Issued To Issue Date Returned Date Status
AMD/NB/017 Meenal Patil 02/05/2025 — In Use

Annexure-3: Notebook Review Checklist

Checklist Item Status Reviewed By Date
All pages used and numbered Yes QA Officer 16/05/2025
Corrections justified Yes QA Officer 16/05/2025

Annexure-4: Notebook Archival Register

Notebook ID Location Archived By Date
AMD/NB/012 Shelf A2 QA Coordinator 01/03/2025

Annexure-5: Notebook Incident Report

Date Notebook ID Issue Reported By Action Taken
05/05/2025 AMD/NB/015 Spilled solvent on pages Ajay Verma Pages scanned and preserved digitally

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded annexures and introduced digital archival guideline Internal audit findings
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: BA-BE Studies: SOP for Ensuring Compliance with Schedule Y Clinical Requirements – V 2.0
Next Post: Elixir Department: SOP for Dispensing of Preservatives for Elixirs – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version